Octanate 500 IU

COMPOSITION

Human coagulation factor VIII

Marketing Authorization

DKI1409300744B1

DOSAGE FORM

INJECTION

Category

HEMOSTATIC / ANTI HAEMOPHILIA

Description

Indication :
Treatment and prevention of bleeding episodes in patients with hemophilia A (congenital or acquired FVIII deviciency), including previously treated patients (PTPs), previously untreated patients (PUPs) and patients undergoing major and minor surgical procedures, and for the treatment of inhibitors by Immune Tolerance Induction (ITI)